AMPLIFY ANSWERS

Scientific and technological services and research and design relating thereto in the field of immune repertoire sequencing; providing clinical diagnostic assays and diagnostic or prognostic testing for detection of minimal residual disease in lymphoid malignancies; development of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expression, namely, cancer biology; research and development in the biotechnology field

Medical services, namely, diagnostic services for the diagnosis and treatment of cancer, auto-immune conditions, and infectious diseases; medical services, namely, providing assays for tracking clones in an immune repertoire over time; medical services, namely, providing analysis, evaluation, and clinical reports of a patient's immune repertoire, including T cell or B cell clonal diversity and clone frequency; medical services, namely, providing diagnostic assays and diagnostic or prognostic testing for residual disease, and the analysis, evaluation, and reports of those test results to help healthcare professionals determine a patient's clinical diagnosis, prognosis or treatment, to assess the effectiveness of patient treatments, and to revise future treatments accordingly